Needham & Company Defends Galena Biopharma (GALE)
Tweet Send to a Friend
Needham & Company analyst Chad Messer, Ph.D. has come out to defend Galena Biopharma (NASDAQ: GALE), which was down 12.4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
